Core Viewpoint - Shengxiang Bio is expanding its industrial chain and strategic layout by establishing a venture capital partnership with Suzhou Weitili New Venture Capital Management Co., Ltd. [1] Group 1: Investment Details - The company plans to invest RMB 20 million as a limited partner, holding a 19.80% stake in the newly formed Changzhou Lingzhong Venture Capital Partnership [1] - The total target subscription amount for the fund is RMB 200 million, with the first fundraising scale set at RMB 10.1 million [1] - The fund will primarily focus on investing in outstanding startups in the healthcare sector, including innovative medical devices, biomedicine, advanced biotechnology, and health management [1]